XJPX7649
Market cap2.77bUSD
Dec 25, Last price
2,408.50JPY
1D
-2.33%
1Q
-8.92%
Jan 2017
-56.68%
Name
Sugi Holdings Co Ltd
Chart & Performance
Profile
Sugi Holdings Co.,Ltd. operates drugstores in Japan. It also provides health counseling services; home-visit prescription dispensing and nursing services; medical consulting; staff agency services; disabled employment promotion; and elderly home care support services. The company operates approximately 1,483 drugstores. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2019‑02 | 2018‑02 | 2017‑02 | 2016‑02 | 2015‑02 | |
Income | ||||||||||
Revenues | 744,477,000 11.51% | 667,647,000 6.74% | 625,477,000 3.81% | |||||||
Cost of revenue | 515,639,000 | 465,123,000 | 433,987,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 228,838,000 | 202,524,000 | 191,490,000 | |||||||
NOPBT Margin | 30.74% | 30.33% | 30.62% | |||||||
Operating Taxes | 10,122,000 | 9,177,000 | 8,066,000 | |||||||
Tax Rate | 4.42% | 4.53% | 4.21% | |||||||
NOPAT | 218,716,000 | 193,347,000 | 183,424,000 | |||||||
Net income | 21,979,000 15.64% | 19,007,000 -1.97% | 19,389,000 -8.20% | |||||||
Dividends | (4,825,000) | (4,912,000) | (4,944,000) | |||||||
Dividend yield | 1.13% | 0.47% | 0.41% | |||||||
Proceeds from repurchase of equity | (8,566,000) | 347,000 | ||||||||
BB yield | 0.82% | -0.03% | ||||||||
Debt | ||||||||||
Debt current | 316,000 | 392,000 | 401,000 | |||||||
Long-term debt | 2,053,000 | 1,562,000 | 1,905,000 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 20,033,000 | 16,989,000 | 16,683,000 | |||||||
Net debt | (65,987,000) | (105,890,000) | (103,918,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 39,041,000 | 38,279,000 | 7,174,000 | |||||||
CAPEX | (32,700,000) | (21,512,000) | (23,379,000) | |||||||
Cash from investing activities | (30,976,000) | (23,256,000) | (23,892,000) | |||||||
Cash from financing activities | (5,284,000) | (14,209,000) | (5,295,000) | |||||||
FCF | 193,049,000 | 196,520,000 | 157,828,000 | |||||||
Balance | ||||||||||
Cash | 47,427,000 | 70,642,000 | 71,831,000 | |||||||
Long term investments | 20,929,000 | 37,202,000 | 34,393,000 | |||||||
Excess cash | 31,132,150 | 74,461,650 | 74,950,150 | |||||||
Stockholders' equity | 226,926,000 | 426,126,000 | 411,749,000 | |||||||
Invested Capital | 223,098,850 | 154,475,350 | 154,435,850 | |||||||
ROIC | 115.85% | 125.18% | 139.33% | |||||||
ROCE | 90.01% | 87.94% | 82.89% | |||||||
EV | ||||||||||
Common stock shares outstanding | 180,956 | 183,085 | 185,441 | |||||||
Price | 2,349.50 -58.78% | 5,700.00 -12.31% | 6,500.00 -12.40% | |||||||
Market cap | 425,155,455 -59.26% | 1,043,586,358 -13.42% | 1,205,365,330 -12.40% | |||||||
EV | 359,168,455 | 1,153,702,358 | 1,314,639,330 | |||||||
EBITDA | 242,959,000 | 214,886,000 | 202,758,000 | |||||||
EV/EBITDA | 1.48 | 5.37 | 6.48 | |||||||
Interest | 15,000 | 16,000 | 19,000 | |||||||
Interest/NOPBT | 0.01% | 0.01% | 0.01% |